|
M.Yu. Krupnova, M.V. Bondarenko, V.V. Marasaev
Chronic kidney disease: risk factors for development and progression
|
№5 / 2013
|
|
N.A. Mikhailova
Phosphate-binder therapy: economical aspects
|
№5 / 2013
|
|
A.P. Rebrov, A.L. Kuklina
Renal dysfunction in patients with arterial hypertension in presense and absense of comorbid conditions
|
№5 / 2013
|
|
A.R. Eraliev, D.M. Demeubaeva, A.E. Naushabaeva, K.A. Kabulbaev, G.N. Chingaeva, B.A. Abeouva, S.M. Dosym, A.B. Kanatbaeva
Neutrophil gelatinase-associated lipocalin in diagnosis of kidney diseases
|
№4 / 2013
|
|
N.A. Mikhailova
Magnesium-containing phosphate-binders: new therapeutic opportunities in chronic kidney disease
|
№4 / 2013
|
|
I.V. Rogova 1, V.V. Fomin 1, I.V. Damulin 1, E.G. Minakova 2, O.Yu Seklivanova 2, E.V. Shashkova 3, Yu.A. Petleva 4
Clinical characteristics and pathogenetic mechanisms of development of cognitive disfucntion in chronic kidney disease patients
|
№4 / 2013
|
|
N.A. Moukhin, L.V. Kozlovskaya, V.V. Fomin, Yu.S. Milovanov
MDRD study: role in clinical nephrology
|
№4 / 2013
|
|
V.A., Zhmurov, D.V. Zhmurov, S.A. Oskolkov, V.G. Yarkova, D.E Kovalchuk., S.V. Artem'eva
Impact of direct renin inhibitor on central hemodynamics parameters and thrombocytes structure and function in patients with chronic kidney disease and arterial hypertension
|
№3 / 2013
|
|
L. Yu. Milovanova, Yu. S. Milovanov, L.V. Kozlovskaya
Nephro- cardioprotective role of the Klotho protein circulating form in patients with chronic kidney disease
|
№3 / 2013
|
|
G.P. Arutiunov, L.G. Oganezova, A.V. Sokolova
Health centers: opportunities and perspectives in early diagnosis of heart failure and kidney involvement in patients with arterial hypertension
|
№1 / 2012
|
|
B.Z. Sirotin
Kidney in patients survived in hantaan and puumala virus-induced nephropathy
|
№2 / 2013
|
|
L.Yu. Milovanova, Yu.S. Milovanov, L.V. Kozlovskaya, N.A. Moukhin
Serum levels of morphogenetic proteins (fibroblast growth factor-23 and Klotho): clinical significance
|
№2 / 2013
|
Русский
